Loading chat...

OK SB1657

Bill

Status

Introduced

2/2/2026

Primary Sponsor

Julie Daniels

Click for details

Origin

Senate

2026 Regular Session

AI Summary

  • Prohibits the manufacture, distribution, mailing, transport, delivery, prescribing, or provision of abortion-inducing drugs (including mifepristone, misoprostol, and methotrexate) in Oklahoma, with exceptions for life-threatening conditions, ectopic pregnancies, and removal of deceased unborn children

  • Enforced exclusively through private citizen "qui tam" lawsuits rather than government prosecution, allowing any person (except state officials) to sue violators within 6 years of the violation

  • Awards successful plaintiffs a minimum of $100,000 per violation plus injunctive relief and attorney fees; affected women, fathers, siblings, or grandparents receive the full award, while other plaintiffs receive $10,000 with the remainder going to a designated charity

  • Exempts hospitals, state-licensed health care facilities, internet service providers, search engines, cloud providers, transportation network companies, airlines, and pregnant women themselves from liability

  • Includes "clawback" provisions protecting Oklahoma residents from out-of-state lawsuits attempting to penalize them for bringing actions under this act, with counter-suit remedies of at least $100,000 or triple damages

Legislative Description

Abortion; prohibiting manufacture or provision of abortion-inducing drugs; authorizing certain qui tam actions. Emergency.

Last Action

Second Reading referred to Health and Human Services

2/3/2026

Committee Referrals

Health and Human Services2/3/2026

Full Bill Text

No bill text available